A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

Clinical trial NCT03725202 · COMPLETED

Trial details

NCT number: NCT03725202
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Giant Cell Arteritis (GCA)

Start date: 2019-01-24
Primary completion: 2024-02-06
Enrollment: 429

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.